Search results for " Recessive"

showing 10 items of 80 documents

Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene

2012

Background. Fabry disease (FD) is an X-linked inherited disease based on the absence or reduction of lysosomal-galactosidase (Gla) activity. The enzymatic defect results in progressive impairment of cerebrovascular, renal and cardiac function. Normally, female heterozygote mutation carriers are less strongly affected than male hemizygotes aggravating disease diagnosis. Method. Close examination of the patients by renal biopsy, echo- and electrocardiography and MRI. Blood work and subsequent DNA analysis were carried out utilizing approved protocols for PCR and Sequencing. MLPA analysis was done to unveil deletions within the GLA gene locus. Quantitative detection of Glycolipids in patient p…

Fabry diseaseTransplantationPathologymedicine.medical_specialtybusiness.industryOriginal ContributionsGenetic disorderLocus (genetics)Heterozygote advantageOriginal Articleslyso-Gb3multiple sclerosismedicine.diseaseBioinformaticsrenal involvementFabry diseaseExonNephrologyMedicineBiomarker (medicine)Multiplex ligation-dependent probe amplificationbusinessX-linked recessive inheritanceClinical Kidney Journal
researchProduct

Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families.

1999

Previously reported linkage of bipolar affective disorder to DNA markers on chromosome 18 was reexamined in a large sample of German bipolar families. Twenty-three short tandem repeat markers were investigated in 57 families containing 103 individuals with bipolar I disorder (BPI), 26 with bipolar II disorder (BPII), nine with schizoaffective disorder of the bipolar type (SA/BP), and 38 individuals with recurrent unipolar depression (UPR). Evidence for linkage was tested with parametric and non-parametric methods under two definitions of the affected phenotype. Analysis of all 57 families revealed no robust evidence for linkage. Following previous reports we performed separate analyses afte…

Genetic MarkersMaleBipolar I disorderBipolar DisorderGenetic LinkageSchizoaffective disorderGenes RecessiveGenetic determinismNuclear FamilyCellular and Molecular NeuroscienceBipolar II disorderGenomic ImprintingChromosome 18GermanymedicineHumansFamilyBipolar disorderMolecular BiologyGenes DominantLinkage (software)GeneticsRecombination GeneticSex CharacteristicsModels GeneticChromosome Mappingmedicine.diseasePsychiatry and Mental healthChromosomal regionFemaleLod ScorePsychologyChromosomes Human Pair 18Molecular psychiatry
researchProduct

The clinical spectrum of alpha-L-iduronidase deficiency.

1985

We present five patients with alpha-L-iduronidase deficiency who do not have the typical Hurler or Scheie phenotypes; they are compared to 28 similarly atypical cases from the literature. Phenotypic differences are pointed out and intrafamilial similarities stressed. Among the various possible explanations for this situation, the existence of genetic compounds seems acceptable for some of the cases, but others seem to be caused by different mutations. The elucidation of these alternative possibilities from recent biochemical research is discussed.

GeneticsMaleAutosomal recessive inheritanceα l iduronidaseAdolescentGlycoside HydrolasesMucopolysaccharidosisMucopolysaccharidosis IInfantBiologyMucopolysaccharidosesmedicine.diseasePhenotypeIduronidasePhenotypeChild PreschoolmedicineHumansFemaleChildGenetics (clinical)American journal of medical genetics
researchProduct

Morphological studies in canine (Dalmatian) neuronal ceroid-lipofuscinosis.

1988

Dalmatian dogs may develop a neuronal or generalized ceroid-lipofuscinosis (NCL) which strongly resembles that seen in English setters, especially as to the ultrastructural changes and ubiquity of the stored lipopigments and the retinal pathology, while differing clinically from the disorder of English setters in that the disease has a longer course of up to 5 or 6 yr. Clinical onset is at about age 6 months; however, an unequivocal morphological diagnosis is possible between the 4th and 5th month of life in biopsied skin. Detailed data of additional investigations are in progress and are awaiting later publication. Thus, NCL in the Dalmatian dog, though not yet as thoroughly investigated a…

GeneticsPathologymedicine.medical_specialtyAutosomal recessive inheritanceDuodenumBrainMuscle SmoothDiseaseDetailed dataBiologymedicine.diseaseClinical onsetRetinaDalmatian dogMicroscopy ElectronDogsNeuronal Ceroid-LipofuscinosesmedicineAnimalsNeuronal ceroid lipofuscinosisPhotoreceptor CellsCanine SpeciesDog DiseasesRetinal pathologyGenetics (clinical)American journal of medical genetics. Supplement
researchProduct

The autosomal recessive (Becker) form of myotonia congenita

1979

In the last two decades, two genetically distinct forms of myotonia congenita have been identified--an autosomal dominant and an autosomal recessive form. The purpose of this review is to describe the features that enable us to distinguish between these two forms in the absence of sufficient genetic data. Thus far, it can be concluded that the only probable difference between the two forms is in the fatty-acid pattern of muscle phospholipids. Clinical, histologic, ultrastructural, and electromyographic investigation may prove helpful, but they alone cannot provide a reliable means of identifying the genotype in an individual patient.

GeneticsPhysiologyMyotonia congenitaGenetic dataHeterozygote advantageBiologymedicine.diseaseCellular and Molecular NeuroscienceErythrocyte membranePhysiology (medical)GenotypemedicineNeurology (clinical)Autosomal recessive formMuscle & Nerve
researchProduct

Estudio genético molecular del síndrome de Usher en España

2005

Usher syndrome (USH) associates deafness and retinitis pigmentosa (RP). It is a disease both clinically and genetically heterogeneous. It is inherited as an autosomal recessive trait and its prevalence makes it the most frequent association of hearing loss and RP. Clinically Usher syndrome is divided into type I (USH1), II (USH2) and III (USH3), according to the severity of hearing loss, age of onset of RP and the existence or not of vestibular dysfunction. There are at least 7 different localizations for USH1 and 5 genes have been identified. For USH2, 3 loci and 2 genes have been reported and USH3 is due to Clarin-1 gene. Our aim is to perform a clinical and genetic characterization of al…

Geneticsmedicine.medical_specialtyGenetic heterogeneitybusiness.industryHearing lossUsher syndromeDiseaseAudiologymedicine.diseaseeye diseasesAutosomal recessive traitOtorhinolaryngologyRetinitis pigmentosaotorhinolaryngologic diseasesmedicineVestibular dysfunctionAge of onsetmedicine.symptombusinessActa Otorrinolaringológica Española
researchProduct

Phenotype traits associated with different alleles at the RPS5 locus in Saccharomyces cerevisiae

1992

The RPS5 gene has been characterised through its ability to reduce invertase production by the SUC5 gene. In this paper we show that RPS5 acts by maintaining low levels of SUC5 mRNA. We also show that RPS5 acts on the SUC1 and SUC4 genes but not on SUC2 and SUC3, which are members of the SUC family. RPS5 also shows a pleiotropic effect on the amount of mitochondrial cytochromes.

Glycoside HydrolasesTranscription GeneticGenes FungalSaccharomyces cerevisiaeGenes RecessiveLocus (genetics)Saccharomyces cerevisiaeSaccharomycesGene Expression Regulation EnzymologicGene Expression Regulation FungalGenes RegulatorGene expressionGeneticsAlleleGeneAllelesGenes DominantRegulator geneGeneticsbeta-FructofuranosidasebiologyGeneral Medicinebiology.organism_classificationPhenotypePhenotypeCytochromesCurrent Genetics
researchProduct

VACTERL with hydrocephalus: A further case with probable autosomal recessive inheritance

1994

Hand deformityGeneticsFatal outcomeAutosomal recessive inheritancebusiness.industrymedicinemedicine.diseasebusinessGenetics (clinical)HydrocephalusAmerican Journal of Medical Genetics
researchProduct

Rapid detection of an Angiotensin Type 2 Receptor Gene variant: no evidence for linkage and association with primary vesicoureteral reflux

2000

Primary vesicoureteral reflux (VUR) affects approximately 1−2% of the general population and is a common cause of end-stage renal failure in children. VUR appears to have a genetic basis and several loci including the Angiotensin Type 2 Receptor Gene (AGTR2) on the X chromosome have been suggested. Using single-strand conformation analysis (SSCA) we typed 103 DNA samples from 17 families with two or more affected individuals for the presence of a splice site mutation in the AGTR2 gene. Linkage analysis revealed a parametric LOD score of −3.977 and a NPL-score of −6,522 by affected-only analysis. Our family-data do not support linkage of VUR to the AGTR2.

Linkage (software)Geneticseducation.field_of_studySplice site mutationPopulationBiologyurologic and male genital diseasesmedicine.diseaseVesicoureteral refluxGenetic linkageGeneticsmedicineeducationGeneGenetics (clinical)X-linked recessive inheritanceX chromosomeGene Function & Disease
researchProduct

Congenital Hepatic Fibrosis

2005

The disease presentation of autosomal recessive polycystic kidney disease (OMIM #263200, ARPKD) is highly variable and includes polycystic kidneys, pulmonary hypoplasia, and congenital hepatic fibrosis. The authors report an unusual case of ARPKD presenting with hepatosplenomegaly and cytopenia mimicking acute leukemia.

Liver CirrhosisMalePathologymedicine.medical_specialtyAdolescentPancytopeniaHepatosplenomegalyurologic and male genital diseasesPulmonary hypoplasiahemic and lymphatic diseasesmedicineHumanscytopeniaPolycystic Kidney Autosomal RecessivesplenomegalyCytopeniaAcute leukemiapolycystic kidney diseasebusiness.industryHematologymedicine.diseasePancytopeniaeye diseasesfemale genital diseases and pregnancy complicationsAutosomal Recessive Polycystic Kidney DiseaseOncologyDisease PresentationPediatrics Perinatology and Child HealthCongenital hepatic fibrosismedicine.symptomTomography X-Ray ComputedbusinessHepatomegalyJournal of Pediatric Hematology/Oncology
researchProduct